Annals Of Pharmacotherapy

杂志介绍

Annals Of Pharmacotherapy杂志介绍

《Annals Of Pharmacotherapy》是一本以Multi-Language为主的未开放获取国际优秀期刊，中文名称药物治疗年鉴，本刊主要出版、报道医学-PHARMACOLOGY & PHARMACY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.3，最新CiteScore 指数为5.7。

本刊近期中国学者发表的论文主要有：

• Postoperative Application of Dexmedetomidine is the Optimal Strategy to Reduce the Incidence of Postoperative Delirium After Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials

  Author: Shang, Limei; Hou, Ming; Guo, Fengying

• The Efficacy and Safety of Sacubitril-Valsartan for the Treatment of Heart Failure in Adults: A Meta-Analysis

  Author: Tian, Qingshan; Xiong, Zhiping; Fan, HouDe; Ning, Ting; Zheng, ZhenZhong

• Effectiveness, Safety, and Predictors of Response to 5% Lidocaine-Medicated Plaster for the Treatment of Patients With Trigeminal Neuralgia: A Retrospective Study

  Author: Yu, Bin; Zhang, Wei; Zhao, Chunmei; Xing, Yan; Meng, Lan; Luo, Fang

• Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations

  Author: Wu, Tingting; Wu, Shuyi; Li, Meijuan; Zhang, Jinhua

英文介绍

Annals Of Pharmacotherapy杂志英文介绍

Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days